Zydus Cadila Healthcare Ltd.
Click on the API name to know their properties
|Composit uses/ indication of FIBATOR EZ :|
Primary hypercholesterolaemia, heterozygous familial hypercholesterolaemia, homozygous familial hypercholesterolaemia or combined hyperlipidaemia.
Lipid-lowering agent, prescribed for hypercholesterolemia.
Hypercholesterolaemia and Hypertriglyceridaemia
|Composit contra indication of FIBATOR EZ :|
Hypersensitivity to Atorvastatin or any component of this medication, Active liver disease, Pregnant, lactating and in women of child-bearing potential.
Hypersensitivity, Moderate to severe liver disease or unexplained serum transaminase elevation, Lactation.
Children, during pregnancy or lactation, in patients with liver insufficiency, presence of gallstones, renal insufficiency, in patients hypersensitive to fenofibrate and/or its excipients.
|Composit side effects of FIBATOR EZ :|
High blood sugar, Abdominal pain, Constipation, Diarrhoea, Indigestion, Nausea, Flatulence. Joint pain, Pain in extremity, Musculoskeletal pain, Muscle spasms, Joint swelling, Rhabdomyolysis. Insomnia. Headache. Fatigue, Pharyngolaryngeal pain, Epistaxis, Liver function test abnormal, Blood creatine phosphokinase increased, Nasopharyngitis.
Gastro-intestinal disturbances, headache, fatigue, myalgia, rarely arthralgia, hypersensitivity reactions, hepatitis, very rarely pancreatitis, cholelithiasis, cholecystitis, thrombocytopenia, raised creatine kinase, myopathy, and rhabdomyolysis.
Digestive, gastric or intestinal disorders (abdominal pain, nausea, vomiting, diarrhea, and flatulence). Rashes, Pruritus, urticaria or photosensitivity reactions.
|Composit caution of FIBATOR EZ :|
Alcoholism. Risk factors for myopathy or rhabdomyolysis. Hypothyroidism.
Patients with history of liver, thyroid, kidney problems, muscle pain, tenderness, weakness, any allergy, during pregnancy and breastfeeding.
Renal or hepatic impairment. Monitor LFTs and blood counts regularly. Increased risk of cholelithiasis, pancreatitis, skeletal muscle effects.
Glaxo Smithkline Pharmaceuticals Ltd.